Epigenetic remodeling via HDAC6 inhibition amplifies anti-tumoral immune responses in myeloid leukemia cells.
Cell death & disease
View this publicationCell death & disease
View this publicationScientific reports
View this publicationCell Death and Disease
View this publicationFrontiers in public health
View this publicationJournal of medicinal chemistry
View this publicationBlood advances
View this publicationJournal of immunology (Baltimore, Md. : 1950)
View this publication